Waters Corp (WAT) stock analysis and fair value
WAT · NYSE · Laboratory Analytical Instruments
445,28 US$
▲ +2,54%
Cerne score
47out of 100
Weak
- Quality74
- Growth50
- Financial strength87
- Valuation0
In 30 seconds
The business. Laboratory Analytical Instruments. Sells 3,2 B US$ a year, keeps 20% as profit and sales grow 6,0% a year (last 5 years).
Strength. Passes 5 of 7 quality checks and could repay its debt with 1,4 years of profit.
WAT fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueWaters Corp key numbers
- Market cap
- 43,7 B US$
- P/E (price ÷ earnings)
- 41,4
- Revenue growth
- 4,3%
- a year, over 9 years
- Profit margin
- 20,3%
- Quality checks
- 5/7
Fiscal 2025 financials, as filed with the SEC.
What analysts say
Buy
21 of 30 analysts recommend buying.
See everything about WAT on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector